Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move ...
While some drugs have fallen off, more have been added: AbbVie recently jumped into the obesity craze by licensing an ...
While many on the right are expectedly exultant about the changes President Trump is making across health and science, STAT’s ...
Pharmalittle: We’re reading about lower Wegovy prices, a dispute over Merck’s Keytruda, and more
Novo Nordisk plans to offer its Wegovy weight loss drug at a reduced cost of $499 per month for cash-paying customers in the ...
Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a ...
Six former chairs of the U.S. Advisory Committee on Immunization Practices explain how the committee works — and why it’s so ...
The NIH cancelled an internship program that gave more than 1,000 college students hands-on research training each summer ...
STAT interviews two dozen scientists and researchers who support some of Trump's aims and finds reservations about a "chaotic ...
To fight U.S. tariffs, the Canadian government should consider suspending patent rights held by U.S. companies, including ...
After a stint at virtual mental health company Cerebral, David Mou is teaming up with Tom Insel to launch a new venture.
For what appears to be the first time, the FDA scolded a company for a promotional display that falsely claimed its ...
The case began with a whistleblower who said UnitedHealth bilked billions of dollars through the Medicare Advantage program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results